Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors

PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00269373

Enrollment

136

Registered

2005-12-23

Start date

2005-12-31

Completion date

2012-02-29

Last updated

2012-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unknown Primary Tumor

Keywords

Unknown primary tumor, PET-CT

Brief summary

Is PET-CT scan better than PET or CT alone in diagnosing primary tumours in patients with unknown primary tumors? Can information obtained with PET-CT replace other clinical and radiological investigations? Is PET/CT cost-effective?

Detailed description

Patients who fulfill the international definition of unknown primary tumors can be included, except: * Young men (\<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included. * Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included. * Women with adenocarcinoma in lymph nodes in the axilla will not be included.

Interventions

PROCEDUREPET-CT

no drugs included

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Unknown primary tumors

Exclusion criteria

* Young men (\<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included. * Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included * Women with adenocarcinoma in lymph nodes in the axilla will not be included

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026